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Interaction of Alkylmercuric Compounds
with Sodium Selenite. I. Metabolism of
Ethylmercuric Chloride Administered
Alone and in Combination with Sodium
Selenite in Rats
by Elzbieta A. Brzeznicka* and Jadwiga Chmielnicka*
The effect of sodium selenite administered intragastrically in repeated doses to rats receiving
ethylmercuric chloride po in various repeated doses (0.25 or 2.5 mg Hg/kg) on the excretion,
whole-body retention, and organ distribution of mercury was studied.
Selenium was found to affect the distribution ofethylmercury among tissues and subcellular
fractions of the kidneys and liver as well as its binding to proteins of soluble fractions in these
organs.
Similarities and differences between the effect of interaction of sodium selenite with
ethylmercuric chloride and methylmercury as well as inorganic mercury are also discussed.
Introduction
Employment of alkylmercury compounds, espe-
cially methylmercurials, in agriculture has resulted
in several epidemic intoxications of humans (1-4).
Ethylmercuric compounds are believed to be gen-
erally less toxic due to more rapid clearance (5, 6).
However, these compounds have been used for a
long time not only in agriculture (1, 7) but also as
antiseptics, among others for preservation ofblood
plasma (8).
Numerous poisonings by ethylmercurials have
been noted, however, in humans (9-13) and in
animals (14, 15). However, available data on the
toxicity, distribution, and metabolism of ethylmer-
curials, constituting a potential danger to living
organisms, are scarce and generally fragmentary,
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and concern mainly single-dose experiments (5, 10,
16-21). On the other hand, for estimation ofchronic
toxicity of alkylmercury compounds, of primary
importance is the extent of their accumulation in
the body, determined by the magnitude and dura-
tion of exposure, uptake rate, biotransformation
efficiency and excretion rate.
Moreover, in the last decade considerable infor-
mation has been gained on the detoxifying role of
sodium selenite in experimental poisoning of ani-
mals with mercuric chloride (22-28) and methyl-
mercury (28-35).
According to some authors, in the case ofmercu-
ric chloride the mechanism ofthe detoxifying action
ofselenium involves a decrease in the renal level of
mercury, and therefore a diminution ofthe nephro-
toxic effect (22, 24, 29, 36), the effect of selenite
depending on its concentration as well as on the
time and kind of exposure (37-42).
Results ofstudies onthemechanismofprotective
action of selenium in poisoning by methylmercury
131compounds are equivocal and sometimes contradic-
tory (27, 43). No analogous data are available for
ethymercurials.
This studydealswithmetabolismofethylmercuric
chloride given rats according to two different
schedules, alone or in combination with sodium
selenite. The scope of the investigations covered
excretion, tissue and organ retention, distribution
in subcellular fractions ofliver and kidneys, as well
as binding to soluble-fraction proteins in these
organs after repeated administration of the above
compounds to animals.
Material and Methods
The experiments were performed on female Wistar
rats weighing 150-200 g, fed standard LSM diet,
and allowed to drink tap water ad libitum. The
animals were divided into four groups of six rats
each. Rats of groups I and II were given
ethylmercuric chloride (EtHg; K and K Laborato-
ries Inc., Plainview, N.Y. USA) in 0.1% sodium
carbonate(Na2CO3, POCh, Gliwice, Poland)through
an intragastrical probe every other day for 14 days.
The animals received 0.25 or 2.5 mg Hg/kg body
weight, respectively, per single dose, labeled with
203Hg (C2H5203HgCl, Radiochemical Centre, Amer-
sham, Bucks., England), 67.2 ,uCi/mg. Animals of
parallel groups Ia and IIa received ethylmercuric
chloride in the same way and, separately, aqueous
solutionofsodiumselenite(Na2SeO4;POCh, Gliwice,
Poland), also intragastrically, 0.5 mg Se/kg per
single dose. Depending on the body weight, the
animals received 0.38-0.50 cm3 of solutions of the
above compounds every time.
At 24 hr after administration of the last dose of
ethylmercuric chloride, rats were sacrificed under
ether narcosis by heart puncture and then appro-
priate organs and tissues were removed.
Mercury was estimated directly by a radiochemi-
cal method from measurement of gamma-radiation
in a USB-2 scintillation counter with a NaI/Tl
crystal. The time of measurement was 100 sec.
Liver and kidneys were fractionated at a tem-
perature of 0-4°C. The organs were homogenized
in 7 volumes of0.25M sucrose + 0.01% NaOH (pH
7.0) in a glass homogenizer (44). The homogenates
wereifitered through agauze and centrifuged twice
at 600g for 15 min to sediment the nuclear fraction
(N). The postnuclear supernatant was centrifuged
twice at 7000g for 15 min to sediment the mitochon-
drial fraction (M). The postmitochondrial superna-
tant was centrifuged once at 12,000g for 10 min.
The sediment contained heavy lysosomes (Lh). The
supernatant was centrifuged at 29,000g for 10 min
to yield the sediment of light lysosomes (L1). The
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remaining supernatant was centrifuged at 144,000g
for 1 hr. The obtained sediment contained micro-
somes (P), and the supernatant corresponded to the
soluble fraction (S) which was then subjected to
Sephadex G-75 chromatography in order to sepa-
ratemercury-bindingproteins. Thechromatographic
column, 2.5 x 60 cm, was eluted with formate
buffer, pH 8.0. The elution rate was 10 cm3/hr; 3
cm3 fractions were collected. The column was
calibrated with: Dextran Blue (MW 2,000,000),
cytochrome c (MW 12,700) and potassium chromate
(MW 194). In the eluates mercury concentration
was estimated as described previously, and protein
concentration was monitored by absorbance mea-
surements at 280 and 250 nm by using a VSU-2P
spectrophotometer.
In the homogenates and individual subcellular
fractions of liver and kidneys, protein was deter-
mined by the method of Lowry et al. (45).
All determinations were made separately for
each animal.
Results
Throughout the experiment, the amount of 203Hg
excreted with feces and urine was monitored daily
in rats exposed to different doses of C2H5203HgCl
alone (groups I and II) or in combination with
sodium selenite groups Ia and IIa (Figs. 1 and 2).
Cumulative excretion ofmercury in feces and urine
during the 2-week exposure in animals of group I
(0.25 mg Hg/kg) and group II (2.5 mg Hg/kg) was
36% (Fig. 3) and 26% (Fig. 4), respectively, of the
administered dose.
Atenfold excess ofselenium (group Ia) decreased
the cumulative 203Hg excretion from 36% to about
28% (Fig. 3). Selenium affected only urinary excre-
tion ofmercury, not the fecal excretion. This effect
was visible in the course ofboth daily and cumula-
tive excretion (Fig. 1).
An equimolar dose of selenium (group Ha) did
not affect the excretion of mercury in the rats as
compared with the group exposed only to ethyl-
mercuric chloride (Figs. 2 and 4).
Retention of mercury in individual tissues and
organs was also studied as a function ofthe dose of
ethylmercuric chloride and the presence or absence
of selenium. The contribution of individual tissues
to the retention ofethylmercuric chloride is shown
as a percentage ofthe cumulative dose in Figures 3
and 4. In rats ofgroup I (Fig. 3)receivingthe lower
doese of ethylmercuric chloride (0.25 mg Hg/kg),
retention was 64%. The metal was most concen-
trated in the kidneys, which retained 21% of the
mercury administered. Blood as well as muscles
and bones played an important role in the accumu-
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FIGURE 1. Cumulative (1) and daily (2) excretion ofEt203Hg in urine and feces during 2-week exposure of
rats to Et203HgCl ± Se: (-) group I (0.25 mg Hg/kg), (x) group Ia (0.25 mg Hg/kg + Se). Bars represent
range from six animals.
lation ofthe compounds studied, eachretaining 17%
of the total mercury given. Liver, intestines, and
skin contained about 5% each, and the content of
mercury in the remaining tissues did not exceed 1%
of the cumulative dose. Brain had the lowest
amount of the accumulated mercury (0.19% of the
metal administered).
The mercury contents in the tissues of rats
exposed to the low dose of ethylmercuric chloride
(0.25 mg Hg/kg) are shown in Figure 5. The lowest
content of this metal (below or about 1 ,ug Hg/g
tissue) was found for brain, muscle, and bones. For
spleen and liver, the content of this metal did not
exceed 3 ,ug/g tissue, and for blood it was 6 ,ug/m3.
On the other hand, the renal content of mercury
was higher by an order ofmagnitude, amounting to
about 60 ,ug/g tissue.
Administration of excess selenium (group Ia)
resulted in similar changes in the tissue levels (Fig.
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5) as in per cent contributions (Fig. 3) of the
respective organs to the retention of Et203HgCl,
i.e., it considerably increased the level of mercury
in brain (from about 0.39 to about 1.37 ,ug Hg/g
tissue), stomach (from about 1.45 to about 5.42 ,ug
Hg/g tissue), and liver (from about 2.6 to about 3.7
,ug Hg/g) and decreased it in kidneys (from 56.9 to
about 13.9 ,ug Hg/g) and blood (from 6.16 to about
4.55 ,ug Hg/m3).
A tenfold higher dose of mercury (2.5 mg Hg/kg)
resulted (Fig. 4) in an increased retention of
mercury as compared with group I. The contribu-
tions of individual organs to the accumulation of
mercury was similar to that observed in group I
except that of kidneys, which was considerably
lower (4.3%), and that of blood, which was higher
(23%). The mercury in blood (Table 1) was almost
completely bound by formed elements (99%).
Administration of a tenfold higher dose of mer-
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FIGURE 2. Cumulative (1) and daily (2) excretion of Et203Hg in urine and feces during 2-week exposure of
rats to EtmsHgCl + Se: (0) group II (2.5 mg Hg/kg), (x) group IIa (2.5 mg Hg/kg + Se). Bars represent
range from six animals.
cury to rats (2.5 mg Hg/kg) resulted in a propor-
tional, tenfold increase of its content in respective
tissues, except for the kidneys where the mercury
content increased as high as twentyfold in compari-
son with the group given a lower dose of
ethylmercuric chloride (Fig. 5).
An equimolar dose of selenium with respect to
mercury (group Ha) did not affect the Et2'Hg
retention (Fig. 4) but altered its distribution in the
body. As in group Ia, selenium increased the
mercury contributions ofliver, stomach, intestines
and brain. Simultaneously, the contribution of kid-
neys to the retention of mercury increased consid-
erably (from about 4.3 in group II to about 9.5% in
group IIa).
An equimolar dose of selenium (group Ha) in-
duced significant changes only in some rat tissues
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(Fig. 6). As in the case of an excess of selenium
(group Ia), an equimolar dose ofthis element with
respect to mercury decreased the concentration of
the mercury in blood (from 110 to about 59 ,ug
Hg/cm3) increasing it simultaneously in brain (from
about 0.26 to about 0.57 ,g Hg/gtissue). However,
this dose of selenium had a different effect on the
content of 203Hg in kidneys which increased (from
about 92 ,ug/gin group II to about213 ,ug/gin group
Ha).
Results from these experiments indicate that the
molarratioofmercuryand seleniumhas asignificant
influence on the retention of mercury in tissues and
organs of rats given ethylmercuric chloride. A
tenfold excess of selenium increased the whole-
bodyretention ofmercury from about 64% in group
I up to about 72% in group Ia (Fig. 3) and induced
Environmental Health Perspectives
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FIGURE 3. Tissuedistribution ofEt203Hg(expressed aspercent
ofcumulative dose) after 2-week exposure to Et203HgCl ± Se
for groups 1 (0.25 mg Hg/kg) and Ia (0.25 mg Hg/kg + Se).
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FIGURE 5. Content of EtmO3Hg in rat tissue after 2-week
exposure to EtIOHgCl Se (means and range from six
animals): (C) group I 0.25 mg Hg/kg; (x) group Ia (0.25 mg
Hg/kg + Se). Organ weight (g) and total blood volume (cm3)
indicated in parentheses.
changes in the organ distribution of mercury (Fig.
5). The concentration of mercury in kidneys de-
creased significantly (from 21% to 4%) while that in
liver, stomach, intestines, muscles, and bones as
well as brain increased. This refers especially to the
brain which accumulated about 4-fold more mer-
cury in this group (Fig. 3).
The content of 203Hg/mg protein in subcellular
fractions of rat kidneys and liver as a function of
dose of ethylmercuric chloride and the presence
sodium selenite is shown in Tables 2 and 3.
In animals of group I (Table 2) the level of
mercury in individual subcellular fractions of the
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Table 1. Contribution of plasma to ethylmercury accumula-
tion after 2-week exposure of rats to Et"'3HgCl ± Se (mean
and range from 6 animals).
EtmOHg in
Group Treatment blood plasma, %
Group I 0.25 mgHg/kg 1,38
1.23-1.55
Group Ia 0.25 mgHg/kg + Se 1.64
1.06-2.17
Group II 2.5 mgHg/kg 0.97
0.74-1.09
Group IIa 2.5 mgHg/kg + Se 0.95
0.86-1.06
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FIGURE 6. Content of Et"3Hg in rat tissues after 2-week
exposure to Et203HgCl ± Se (means and range from six
animals): (-) group II (2.5 mg Hg/kg); (x) group IIa (2.5 mg
Hg/kg + Se). Organ weight (g) and total blood volume (cm3)
indicated in parentheses.
liver ranged from about 0.008 (light lysosomes) to
about 0.020 ,ug Hg/mg protein (membranes, soluble
fraction and microsomes).
The higher dose of mercury (group II) which
induces atenfold increase in the mercury content of
this tissue (Fig. 5) led to aroughly equal increase in
the concentrations of this metal in hepatic organ-
elles. An exception was the microsomal fraction,
where the increase was about twentyfold.
Sodium selenite in the liver of rats receiving a
lower dose ofmercury (group Ia) tended to increase
the 203Hg content of all fractions, but differences
were minimal.
An equimolar dose of selenium with respect to
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mercury (group IIa) induced an increase of 203Hg
concentration in mitochondrial and lisosomal frac-
tions. Simultaneously, a decrease of mercury con-
tent in microsomal and soluble fractions was ob-
served.
In the soluble fraction of liver, mercury was
bound by high molecular weight proteins (Fig. 7),
and the amount of the metal present in the peak
corresponding to these proteins was dependent on
the concentration of mercury in the total of the
soluble fraction.
Sodium selenite did not affect the binding of
ethylmercury in this fraction ofthe liver, irrespec-
tive of the dose.
For kidneys ofrats ofgroup I (Table 3), the level
ofmercury in individual subcellularfractions ranged
from 0.182 (light lysosomes) to 0.681 ,ug Hg/mg
protein (soluble fraction).
The higher dose ofethylmercuric chloride (group
II) which increased the level of mercury in this
tissue twofold (Fig. 6) also elevated the mercury
content of the subcellular fractions, as compared
with group I. Exceptions were the nuclear, mito-
chondrial, and heavy lysosomal fractions where no
changes were found in the content ofthis metal as
compared with Group I (Table 3).
Administration of excess selenium with respect
to mercury (group Ia) which decreased the level of
mercury in the kidneys (Fig. 5) decreased its
concentrations in individual fractions. The highest,
about a tenfold decrease, took place in the soluble
fraction (from about 0.681 to about 0.079 ,ug Hg/mg
of protein).
On the otherhand, an equimolar dose ofselenium
(group Ha), which enhanced the mercury content of
the kidneys (Fig. 6), increased similarly its levels in
the organelles. The greatest increases were ob-
served for the microsomal fraction (from about
0.616 to 5.109 ,ugHg/mgprotein). Anexception was
the soluble fraction, where no changes were found
in the content ofthis metal as compared with group
II (Table 3).
The binding pattern of 203Hg to the soluble-
fraction proteins of kidneys of rats exposed to
ethylmercuric chloride given in different doses
alone or in combination with sodium selenite is
shown in Figure 8.
In animals exposed to 0.25 mg Hg/kg, about 65%
of the mercury present in the soluble fraction was
bound to proteins of molecular weight of about
10,000, i.e., metallothionein-like proteins (Fig. 8).
High molecular weight proteins bound about 17.60
and 18.05% mercury, respectively, depending on
the molecular weight.
Inthe case ofahigh dose ofmercury (2.5mg/kg),
metallothionein-like proteins dominated in the bind-
Environmental Health PerspectivesTable 2. Ethylmercury in subcellular fractions ofrat liver after 2-week exposure to Et203HgCl with or without sodium selenite
(mean and range from 4 animals).
Et203Hg,Rg/mg protein
Subcellular Group I Group Ia Group II Group IIa
fractions (0.25 mg Hg/kg) (0.25 mg Hg/kg+Se) (2.5 mg Hg/kg) (2.5 mg Hg/kg + Se)
H 0.014 0.019 0.146 0.489
0.012-0.017 0.014-0.030 0.139-0.159 0.137-0.548
Ms 0.024 0.035 0.140 0.144
0.008-0.062 0.018-0.060 0.126-0.153 0.128-0.177
N 0.010 0.019 0.154 0.160
0.006-0.012 0.010-0.035 0.054-0.275 0.116-0.246
M 0.016 0.012 0.086 0.187
0.008-0.022 0.009-0.015 0.067-0.106 0.104-0.299
Lh 0.012 0.012 0.083 0.181
0.008-0.015 0.008-0.014 0.054-0.113 0.150-0.224
Li 0.008 0.012 0.115 0.320
0.006-0.011 0.008-0.017 0.082-0.147 0.085-0.572
P 0.021 0.026 0.469 0.217
0.018-0.023 0.019-0.035 0.305-0.633 0.167-0.296
S 0.022 0.017 0.234 0.178
0.016-0.032 0.012-0.020 0.187-0.267 0.164-0.189
Table 3. Ethylmercury in subcellular fractions of rat kidneys after 2-week exposure to Et203HgCl with or without sodium
selenite (mean and range from 4 animals).
Et203Hg,,ug/mg protein
Subcellular Group I Group Ia Group II Group IIa
fractions (0.25 mg Hg/kg) (0.25 mg Hg/kg+Se) (2.5 mg Hg/kg) (2.5 mg Hg/kg + Se)
H 0.311 0.081 0.472 1.105
0.287-0.357 0.067-0.102 0.426-0.498 0.812-1.309
Ms 0.232 0.109 0.340 0.725
0.148-0.345 0.096-0.118 0.272-0.409 0.329-0.940
N 0.202 0.108 0.205 1.854
0.183-0.226 0.032-0.257 0.109-0.309 1.655-2.039
M 0.370 0.046 0.353 1.941
0.280-0.479 0.032-0.069 0.353-0.353 1.013-2.415
Ln 0.424 0.107 0.439 1.169
0.359-0.488 0.055-0.158 0.402-0.482 0.976-1.356
Li 0.182 0.060 2.547 1.074
0.171-0.194 0.059-0.060 1.800-4.361 0.532-1.505
P 0.429 0.223 0.616 5.109
0.169-0.690 0.223-0.223 0.508-0.706 2.127-8.159
S 0.681 0.079 0.716 0.810
0.521-1.010 0.073-0.082 0.668-0.776 0.661-0.926
ing too, containing ca. 46% of the metal present in
the soluble fractions of the kidneys (Table 4).
Sodium selenite, when administered in a tenfold
excess with respect to mercury, did not displace the
latter completely from low molecular weight pro-
teins. It did cause a decrease in the mercury
content of individual peaks, probably due to the
diminution of the total mercury content of the
kidneys (Fig. 5), especially of the soluble fraction
(Table 3), but the distribution ofthis metal between
the peaks remained relatively unchanged (Table 4).
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The percentage of total mercury bound to low
molecular weight proteins still contained about 50%
ofthe total mercury present in the soluble fraction.
After administration of an equimolar dose of
selenium with respect to mercury (group Ila) only
slight changes were observed, indicative of a small
decrease in the contribution oflow molecularweight
proteins in the binding ofmercury (from 46.35% in
group II to 34.8% in group Ila) in favor of high
molecularweightproteins. However, the amount of
this metal bound by protein classes of different
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FIGURE 7. Separations ofsoluble fraction ofrat liver after 2-week exposure to Et2o:IHgCl ± Se: (1) group I
(0.25 mgHg/kg); (2) group Ia(0.25 mgHg/kg + Se); (3) group II (2.5 mgHg/kg), (4) group IIa(2.5 mgHg/kg
+ Se). Sephadex G-75 columneluted with buffer asdescribed in Methods. The curves correspond to ( )
A280, (- -) A250, and (-) ,ug203Hg. Arrows indicate the position of Dextran Blue, Cytochrome c, and
K2CrO4.
molecular weight did not change significantly (Table
4), probably due to the unchanged total mercury
content of the soluble fraction.
Discussion
Theresultspresented hereindicatethatthe processes
of uptake, redistribution, and excretion of ethyl-
mercuric chloride in the rat follow a pattern similar
to that of methylmercuric chloride. However, its
high accumulation in kidneys resembles the in vtvo
behavior of inorganic mercury.
This work indicates a high retention of ethyl-
mercuric chloride in rats under conditions ofchronic
exposure, ranging from 64 to 74% after administra-
tion of doses differing by an order of magnitude.
This retention was 20% lower than retention of
methylmercuric chloride administered in the same
(46) or similar doses (47).
Ethylmercuric chloride, like methylmereuric chlo-
ride, is excreted mainly in feces. The ratio of the
amount of mercury excreted in urine to- that ex-
creted in feces during two weeks was about 1:8
(Fig. 1) or 1:10 (Fig. 2), respectively, depending on
the dose. Urinary excretion of mercury was higher
138
at lower and single doses (16, 17), being the ratios
were 1:5 and 1:2, respectively.
Literature data onthemetabolism ofethylmercuric
chloride are scarce and fragmentary and concern
mainly dynamics of ethylmercury decay only in
certain tissues after single (6, 10, 16-18, 21) or
repeated doses (48, 49). These data indicate that
the kidneys were especially efficient in accumula-
tion of mercury in the experimental animals. More-
over, a tendency was demonstrated for a progres-
sive accumulation of this compound in rat (17) and
mouse kidneys (10) with time after administration
of a single dose. Our previous studies indicate that
of different mercury compounds administered in
rats (methylmercurycyanguanidine, ethyl- and
phenylmercuric chloride, and mercuric chloride),
the highest concentrations of mercury in the kid-
neys werefoundafteradministrationofethylmercuric
chloride (50). However, contribution of kidneys to
the retention of mercury decreased with repeated
exposure and withincreasingdoses ofethylmercuric
chloride (Figs. 3 and 4). This is probably due to a
limited binding capacity of specific renal proteins
for mercury.
Apart from the soluble fraction in the kidneys,
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FIGURE 8. Separations ofsoluble fraction ofratkidneys after2-weekexposure toEt203HgCl + Se: (1)group
1(0.25 mg Hg/kg); (2) group Ia (0.25 mg Hg/kg + Se); (3) group II (2.5 mg Hg/kg); (4) group Ila (2.5 mg
Hg/kg + Se). SephadexG-75columnelutedwithbufferasdescribedinMethods. Thecurvescorrespond to
(-) A280, (- -) A25o, and ( ) ,ug203Hg. Arrows indicate the position of Dextran Blue, Cytochrome c,
and K2rO4.
Table 4. Content of ethylmercury in peaks of mercury-
binding proteins of the soluble fraction of rat kidneys after
2-weekexposure ofrats toEt203HgCl ± Se; proteins separated
by Sephadex G-75 chromatography.
EtHg content, %
Treatment Peak 1 Peak 2 Peak 3 Peak 4
Group I (0.25 mg Hg/kg) 17.60 18.05 64.33 -
Group Ia (0.25 mg Hg/kg + Se) 21.18 22.60 50.30 -
'Group II (2.5 mg Hg/kg) 14.60 29.80 46.35 9.25
Group Ila (2.5 mg Hg/kg + Se) 32.70 31.20 34.80 -
irrespective of the dose, other cellular organelles
also played an important role in the accumulation of
ethylmercury. In this respect ethylmercuric chlo-
ride behaved unlike inorganic mercury which was
accumulated more efficiently in the soluble fraction
ofthe kidneys, chiefly bound tometallothionein-like
proteins (37, 40, 51-53).
On the otherhand, it has been noticed previously
(53) that ethylmercuric chloride, like HgC12, in-
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duces a statistically significant increase in the level
of metallothionein-like proteins in kidneys of rats
exposed chronically to this compound. It resulted
from those studies, too, that irrespective of the
dose of ethylmercuric chloride, mercury present in
the soluble fraction of the kidneys was bound
mainly to low molecular weight proteins (Fig. 8)
and the contribution of these proteins was higher
than after a single dose of this compound (5).
Probably these proteins bind chiefly inorganic mer-
cury released from ethylmercuric chloride by
biodegradation, and this process is determined by
magnitude of the dose (54).
It has been found, too, that at high doses of
ethylmercury when the contribution of kidneys to
the accumulation of mercury is decreased, that of
blood is increased (Fig. 4). This efficient accumula-
tion of ethylmercury in blood of experimental
animals in combination with the slow atrophy of
this tissue (10, 16, 17, 21) results in accumulation of
mercury in brain, the organ believed to be critical
in poisoning with alkylmercurials (2, 4, 55, 56).
139It is noteworthy that the brain:blood mercury
concentration ratio, calculated on the basis oftotal
Et203Hg concentration in these tissues of rats, is
fairly constant at 0.01, irrespective of the dose of
ethylmercury and of the kind of exposure.
In the case ofinteraction between ethylmercuric
chloride and sodium selenite, the blood:brain mer-
cury concentration ratio was observed to increase
severalfold as compared with values obtained for
animals exposed to ethylmercuric chloride alone.
The constant ratio of mercury concentrations in
brain and blood indicates that the level ofmercury
in rat brain depends on its level in blood and can be
calculated from the latter as in the case of
methylmercury in humans. It should be emphasized
onthe basis ofthese observations that high doses of
ethylmercury which could be deposited in kidneys
only to alimited extent but which are progressively
accumulated in blood constitute a potential danger
of a sudden appearance of ethylmercury poisoning
symptoms. Similar results have been observed for
methylmercury (57).
A characteristic feature of interaction between
HgC12 and sodium selenite administered in equimo-
lar doses is an increase in the whole-body retention
ofmercury and a decrease in the levels ofthis metal
in kidneys with concomitant increases in liver and
blood (23, 40, 47, 58). This may be due to formation
ofstable complexes ofthese elements with proteins
in liver and blood (38, 59, 60). Occurrence of
complexes ofthis type have been demonstrated for
other rat tissues (61).
In the case ofethylmercuric chloride, an equimo-
lar dose of selenium not only did not decrease but
even increased the mercury content of rat kidneys
(Figs. 4 and 6). A small excess of selenium did not
alter the level of mercury in this organ (50). The
effect ofdiminution ofthe mercury level afterexposure
to ethylmercuric chloride was observed only after
application of a tenfold selenium excess (Fig. 5).
Contrary to the interaction between HgCl2 and
sodium selenite, even a tenfold excess ofthe latter
did not result in a shift ofethylmercury from low to
high molecular weight proteins, inducing only a
decrease in the concentrations of this metal in
appropriate peaks (Fig. 8).
Similarity between ethylmercury and HgCl2 in
the interaction with selenium can be observed for
the ratonlyinkidneys and exclusively forlowdoses
of ethylmercury. It concerns probably only the
inorganic mercury released from the alkyl linkage,
as the process of biotransformation of low doses of
ethylmercury in rats proceeds in kidneys with a
high efficiency, both after single (10) and repeated
exposure (50). This question is the subject of our
further studies.
We wish to thank Mrs. Honorata Pilarek for excellent
technical assistance and for her help in the preparation of the
figures.
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